WORXE Worlds Online Inc

MariMed Granted Three Adult-Use Licenses in Massachusetts

MariMed Granted Three Adult-Use Licenses in Massachusetts

NORWOOD, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that at their August 6th session the Massachusetts Cannabis Control Commission (“CCC”) gave final approval to issue the Company three adult-use licenses for cultivation, production, and retail, subject to final inspections.

The cultivation and production licenses will be deployed at its 70,000-square-foot cannabis manufacturing facility in New Bedford, Mass., and the retail license at its Panacea Wellness™ Dispensary in Middleborough, Mass. The Company continues to actively develop two additional dispensary locations for its other provisional adult use and medical licenses.

Bob Fireman, Chief Executive Officer of MariMed, commented, “Adding adult-use sales at Panacea Wellness will open a huge revenue opportunity to our already booming Massachusetts wholesale and retail business. This 10,000 square foot dispensary is located on a heavy traffic road between two major highways connecting many southeastern Massachusetts towns. This will be a destination for our loyal consumers to purchase our top selling brands, Nature’s Heritage flower and Betty’s Eddie’s fruit chews. We expect the final inspection on or before September and to open immediately thereafter.”

According to BDS Analytics, Massachusetts retail cannabis sales in 2019 were $587 million, growing to exceed $745 million in 2020, and the firm expects this market will conservatively reach $1.35 billion by 2024. Today, consumers in the Massachusetts spend an average of $140 a month on cannabis products, or almost 200% above the nationwide average.

Tim Shaw, Chief Operating Officer of MariMed, said, “My team has worked long and hard to secure these licenses. Our state-of-the-art cultivation, production, and dispensary facilities developed under the state medical cannabis program were designed for and are ready to support added production of our top-rated flowers and products into the robust Massachusetts Adult Use marketplace. Thank you to our team and to the CCC for making this possible.”

To be added to the email distribution list, please email with “MRMD” in the subject.

About MariMed:

MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units.

The Company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry-leading products and brands, including "Betty's Eddies™”, “Nature’s Heritage™”, “Bourne Baking Co.", and “Kalm Fusion”. These precision dosed products are focused on specific symptoms and conditions and are licensed and distributed across the country.

For additional information, visit marimedinc.com.

Important Caution Regarding Forward-Looking Statements:

This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.'s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events, including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected," "looks" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

All trademarks and service marks are the property of their respective owners.

Company Contact

Jon Levine, CFO

MariMed Inc.

Tel (781) 559-8713

Media Contact

Abigail Diehl

MariMed Inc.

Annie Graf

KCSA Strategic Communications

Investors

KCSA Strategic Communications

Scott Eckstein / Elizabeth Barker

EN
12/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

 PRESS RELEASE

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries MariMed Debuts Original Song Inspired by a U.S. Army Veteran’s Experience, Supporting FreedomSingsUSA, and Strengthening its Commitment to Veteran-Focused Initiatives NORWOOD, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, today announced an inspiring new initiative sparked by U.S. Army veteran and MariMed dispensary customer Ryan Taylor. After years of battling the physical and emotional wounds o...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Winter Season...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty’s Bundle Up Betty’s Uses Real Cranberry, Orange, and Warming Spices in Each Fruit Chew to Deliver Cozy Winter Wind-Downs NORWOOD, Mass., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ™, the all-natural, cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of cranberry orange chews for the winter: Bundle Up Betty’s. Betty’s Eddies is one of the top-selling and award-winning brands developed and distributed...

 PRESS RELEASE

MariMed Reports Third Quarter 2025 Earnings

MariMed Reports Third Quarter 2025 Earnings NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quarter ended September 30, 2025. Management Commentary “During the third quarter, we continued to make progress on our plan to own top-selling, national consumer cannabis brands, while also delivering sequential increases in revenue, adjusted EBIDTA, and operating cash flow,” said Jon Levine, MariMed Chief Exe...

 PRESS RELEASE

MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selli...

MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers NORWOOD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced manufacturing and distribution agreements that enable the Company to launch their market leading beverage and edibles brands, including and , into the rapidly growing hemp-derived THC market. This initiative is part of MariMed’s broader Expand the Brand strategy to extend its award-winning portfol...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch